Tech Company Financing Transactions

Argos Therapeutics Funding Round

Forbion Capital Partners, Aurora Funds and Intersouth Partners participated in a $25 million Series D funding round for Argos Therapeutics. The funding round was recorded on 4/24/2012.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

4233 Technology Dr.
Durham, NC 27704
USA

Phone

(919) 287-6300

Website

www.argostherapeutics.com

Email Address

[email protected]

Overview

Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis technology platform.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Abbey

        

Chief Financial Officer

Richard Katz

        

Chief Scientific Officer

Charles Nicolette

        

VP - Finance

Lori Harrelson

        

Browse more venture capital transactions:

Prev: 4/24/2012: FTRANS venture capital transaction
Next: 4/24/2012: Visible Technologies venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary